Intra-arterial injection to create bone metastasis of prostate cancer in mice.

Intra-arterial injection to create bone metastasis of prostate cancer in mice. Am J Clin Exp Urol. 2020;8(4):93-100 Authors: Zhong L, Miller HD, Zhang Y, Jin B, Ge D, You Z Abstract Human prostate cancer often metastasizes to the bone, but the mechanisms are not quite clear. The difficulties in studying the biology of bone metastasis are due to lack of animal models with high frequency of bone metastases. In the present study, we tested two intra-arterial injection methods, i.e., intra-caudal artery injection and intra-femoral artery injection. Mouse prostate cancer cell line MPC3-luc was injected into C57BL/6J male mice via intra-caudal artery injection (n = 8) or intra-femoral artery injection (n = 11). We found one mouse developed metastatic tumors in both hind limbs and the tail after intra-caudal artery injection. Two mice developed metastatic tumors in the hind limb after intra-femoral artery injection. The metastatic tumors were detected by bioluminescent imaging and X-ray, and confirmed by histological examination. Our study finds that intra-arterial (either caudal or femoral artery) injection may be a useful model in studying prostate cancer bone metastasis, however, the injection technique is difficult. PMID: 32929404 [PubMed]
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Tags: Am J Clin Exp Urol Source Type: research

Related Links:

Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
Authors: Matti B, Zargar-Shoshtari K Abstract Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health professionals and epidemiologists, since PSA as a screening tool seemed to be far from perfect. In New Zealand, the controversy was quite prominent in the last three decades, with some advocating the benefits of screening, while others concerned regarding the risk of harms. With the absence of an organised screening programme and ...
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Authors: Zarrabi A, Mark S PMID: 33032299 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Publication date: Available online 7 October 2020Source: European UrologyAuthor(s): Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G. Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Jeremy Grummet, Ann M. Henry, Theodorus H. van der Kwast, Thomas B. Lam, Michael Lardas, Matthew Liew, Malcolm D. Mason, Lisa Moris, Daniela E. Oprea-Lager
Source: European Urology - Category: Urology & Nephrology Source Type: research
Authors: Zhao Y, Cheng X, Wang G, Liao Y, Qing C Abstract Linalool is an unsaturated terpene that can be found in several plants and exhibits various biological activities. The aim of the present study was to investigate the anticancer activity of linalool using the human prostate cancer 22Rv1 cell line. Flow cytometry was employed to study the effects of linalool on the induction of apoptosis, cell cycle progression, loss of mitochondrial membrane potential and cytochrome c release, whereas the effects of linalool on apoptosis-associated proteins were investigated by western blot analysis. An efficacy study was co...
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research
Kathy Siggins and Lynda Everman are thrilled to share the welcome news that the US Postal Service has reinstated sales of the Alzheimer’s Disease Research Semipostal Stamp effective October 5, 2020. It is now available for purchase at most post offices and online at https://store.usps.com/store/product/buy-stamps/alzheimers-S_564204, and by phone at 1-800 STAMP-24. Before it was withdrawn in November 2019, over 8.2 million stamps were sold during its two-year run raising $1,061,777 for NIH-supported research to advance better treatments, prevention, and one day, a cure of Alzheimer’s and related dementias. The ...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
AbstractLike other malignancies, prostate tumors are thought to contain cancer stem-like cells (CSCs) that are responsible for growth, metastasis, and therapy resistance. ΔNp63 (also called p40) is a regulator of normal prostate stem/progenitor cell activities and a marker of normal basal epithelial cells. The levels of ΔNp63 are reduced in prostate adenocarcinomas, although there is also evidence that ΔNp63 is involved in CSC regulation and drives metastasis to t he bone. We studied metastatic deposits of prostate cancers with isoform-specific ΔNp63 and TAp63 antibodies. We identified p63-positive ...
Source: Virchows Archiv - Category: Pathology Source Type: research
AbstractBackgroundEnzalutamide is a novel, non-steroidal anti-androgen that has demonstrated excellent anti-tumor activity for both non-metastatic and metastatic castration-resistant prostate cancer (nmCRPC and mCRPC) patients, and that is being rapidly introduced into clinical practice in Japan.ObjectiveWe retrospectively investigated the treatment efficacy, safety profile, and prognostic factors of enzalutamide over a relatively long observation period in Japanese patients with nmCRPC and mCRPC.Patients and methodsThe medical records of 184 consecutive Japanese patients with nmCRPC and mCRPC who started enzalutamide trea...
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
ConclusionsThe findings from the study provided practical guidance for future clinicians when implementing a prehabilitation program. Future study is required to evaluate the effectiveness of such a prehabilitation program in improving patient engagement and preparedness for prostate cancer treatment.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
Authors: Zhang X, Pang P, Jiang M, Cao Q, Li H, Xu Y, Li Y, Chen X, Han J Abstract Prostate cancer (PCa) is one of the most commonly diagnosed cancers in males worldwide. lncRNAs (long noncoding RNAs) play a significant role in the occurrence and development of PCa. eRNAs (enhancer RNAs) and SE-lncRNAs (superenhancer lncRNAs) are important elements of lncRNAs, but the role of eRNAs and SE-lncRNAs in PCa remains largely unclear. In this work, we identified 681 eRNAs and 292 SE-lncRNAs that were expressed differentially in PCa using a microarray. We also found that eRNAs transcribed from active open chromatin had sig...
Source: Disease Markers - Category: Laboratory Medicine Tags: Dis Markers Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Prostate Cancer | Study